2BB score and signals
Humacyte, Inc.’s current 2BB score is 46 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 56 | Moderate |
| Momentum | 54 | Stable |
| Financial strength | 14 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 58 | Moderate |
Company facts
| CEO | Laura Niklason |
| Founded | Jan 1, 2004 |
| Employees | 184 |
| 52-week range | $0.55 – $2.55 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.0836 | — | $781,320.00 |
| 2026-08-12 | — | -0.102 | — | $1.14M |
| 2026-05-13 | -0.09 | -0.1185 | $495,000.00 | $1.48M |
| 2026-03-27 | -0.13 | -0.1343 | $467,000.00 | $1.37M |
Related companies
